Dr. Dennis F. Moore

Claim this profile

Ascension Via Christi Hospitals Wichita

Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
30 reported clinical trials
80 drugs studied

Area of expertise

1Lung Cancer
Dennis F. Moore has run 7 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage II
Stage III
2Non-Small Cell Lung Cancer
Dennis F. Moore has run 7 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Stage IV
Stage II
Stage III

Affiliated Hospitals

Image of trial facility.
Ascension Via Christi Hospitals Wichita
Image of trial facility.
Cancer Center Of Kansas-Wichita Medical Arts Tower

Clinical Trials Dennis F. Moore is currently running

Image of trial facility.

Osimertinib + Bevacizumab

for Lung Cancer

This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Image of trial facility.

Lomustine + Standard Therapy

for Glioblastoma

This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria

More about Dennis F. Moore

Clinical Trial Related4 years of experience running clinical trials · Led 30 trials as a Principal Investigator · 18 Active Clinical Trials
Treatments Dennis F. Moore has experience with
  • Radiation Therapy
  • Atezolizumab
  • Pembrolizumab
  • Carboplatin
  • Stereotactic Body Radiation Therapy
  • Biospecimen Collection

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dennis F. Moore specialize in?
Dennis F. Moore focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage II.
Is Dennis F. Moore currently recruiting for clinical trials?
Yes, Dennis F. Moore is currently recruiting for 17 clinical trials in Wichita Kansas. If you're interested in participating, you should apply.
Are there any treatments that Dennis F. Moore has studied deeply?
Yes, Dennis F. Moore has studied treatments such as Radiation Therapy, Atezolizumab, Pembrolizumab.
What is the best way to schedule an appointment with Dennis F. Moore?
Apply for one of the trials that Dennis F. Moore is conducting.
What is the office address of Dennis F. Moore?
The office of Dennis F. Moore is located at: Ascension Via Christi Hospitals Wichita, Wichita, Kansas 67214 United States. This is the address for their practice at the Ascension Via Christi Hospitals Wichita.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security